Prof. Klaus Cichutek, PhD

BiographyProf. Klaus Cichutek, PhD

Klaus Cichutek is President of the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany, and extra-ordinary Professor of Biochemistry at the GoetheUniversity Frankfurt/Main.

The Paul-Ehrlich-Institut is a research and science driven Medicines Agency (veterinary and human vaccines, human biomedicines) reporting to the German Federal Ministry of Health and providing regulatory services to the European Medicines Agency EMA, EDQM, WHO and others.

Professional career:

  • 1976 to 1984       studies of and Ph.D. in biochemistry
  • 1985 to 1988      postdoctoral scientist at the Molecular Biology and Virus Laboratory, University of California in Berkeley, U.S.A., on fellowships of the DFG (German Research Foundation) and the Univ. of California
  • 1988 to 1994      head, ‘Molecular Biology’ Research Group, Paul-Ehrlich-Institut, Langen
  • 1994 to 2011      head, Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen
  • 1999 to 2009      Vice President, Paul-Ehrlich-Institut, Langen
  • 2009 to today      President, Paul-Ehrlich-Institut, Langen

Research interests:Retrovirology and gene therapy (> 150 publications).
Early research on oncogenic Harvey sarcoma virus was followed by a characterisation of the apathogenic infection of African green monkeys with SIVagm and of the development of HIV-1 virus variants from a single biological virus clone in patients. In gene therapy, he generated a variety of retro- and lentiviral vectors and vector pseudotypes and he demonstrated the feasibility of cell targeting in vitroand in vivo.

Current committee and board memberships (selection):

  • Management Group chair of the European “Heads of Medicines Agencies” (HMA; 02/2014 to 02/2018),
  • “WHO Expert Committee on Biological Standardization” (ECBS) (elected chair in 2016/17/18),
  • “WHO Product Development for Vaccines Advisory Committee” (PD-VAC),
  • ICMRA member (“International Coalition of Medicines Regulatory Authorities”),
  • founding member of the German Center for Infection Research DZIF,
  • reviewer of research proposals for the Federal Ministry of Education and Research, the German Research Foundation DFG, Fraunhofer, Helmholtz Association and the European Commission.